Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06710938 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Thoracoabdominal Artery Stent Graft System Exploratory Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Feb 2031 to Jun 30, 2028
    • Study completion date: Feb 2031 to Jun 30, 2032
    • Site contact updated
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2025 to Jul 24, 2025
    • Site details revised
    v3
  3. Start date: Feb 2025 to May 2025v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is designed as a single-center, prospective, single-arm, open-label, exploratory study. The objective is to evaluate the feasibility of Thoracoabdominal Artery Stent Graft System for endovascular treatment of Thoracoabdominal aortic aneurysms (TAAA).
Trial Details
NCT Number NCT06710938
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Conditions
(from sponsor)		 Thoracoabdominal Aortic Aneurysms
Related terms Aortic Aneurysm, Thoracoabdominal
Enrollment 11 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov